Tetra Bio Pharma Inc
TSX:TBP
Tetra Bio Pharma Inc
TSX:TBP
Price:
0.025
CAD
Market Closed
Market Cap:
CA$10.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Tetra Bio Pharma Inc
TSX:TBP
|
CA |
|
E
|
Empyrean Energy PLC
LSE:EME
|
AU |
|
P
|
Philippine Seven Corp
XPHS:SEVN
|
PH |
|
Nanovibronix Inc
NASDAQ:NAOV
|
US |
|
C
|
China Sunsine Chemical Holdings Ltd
SGX:QES
|
SG |
|
Pharnext SCA
OTC:PNEXF
|
FR |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
|
V
|
Vinyl Chemicals India Ltd
NSE:VINYLINDIA
|
IN |
|
FRONTEO Inc
TSE:2158
|
JP |
|
J
|
Jiangsu Times Textile Technology Co Ltd
SZSE:001234
|
CN |
|
Want Want China Holdings Ltd
HKEX:151
|
CN |
Income Statement
Earnings Waterfall
Tetra Bio Pharma Inc
Tetra Bio Pharma Inc
Income Statement
Tetra Bio Pharma Inc
Tetra Bio Pharma Inc
Currency: CAD
| Nov-2012 | Feb-2013 | May-2013 | Aug-2013 | Nov-2013 | Feb-2014 | May-2014 | Aug-2014 | Nov-2014 | Feb-2015 | May-2015 | Aug-2015 | Nov-2015 | Feb-2016 | May-2016 | Aug-2016 | Nov-2016 | Feb-2017 | May-2017 | Aug-2017 | Nov-2017 | Feb-2018 | May-2018 | Aug-2018 | Nov-2018 | Feb-2019 | May-2019 | Aug-2019 | Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(2)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(4)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(8)
|
(13)
|
(13)
|
(14)
|
(13)
|
(14)
|
(15)
|
(16)
|
(20)
|
(25)
|
(28)
|
(29)
|
(24)
|
(44)
|
(16)
|
(13)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(3)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(10)
|
(13)
|
(14)
|
(12)
|
(10)
|
(8)
|
(6)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
0
|
(3)
|
(3)
|
(4)
|
(6)
|
(7)
|
(7)
|
(8)
|
(6)
|
(6)
|
(6)
|
(8)
|
(12)
|
(14)
|
(15)
|
(14)
|
(12)
|
(9)
|
(8)
|
(7)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(25)
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(1)
-28%
|
(0)
+68%
|
(0)
+31%
|
(0)
-45%
|
(2)
-1 213%
|
(0)
+93%
|
(0)
-29%
|
(0)
-72%
|
(1)
-110%
|
(1)
-11%
|
(1)
+11%
|
(1)
+2%
|
(0)
+30%
|
(0)
N/A
|
(1)
-27%
|
(1)
-86%
|
(2)
-96%
|
(4)
-92%
|
(5)
-32%
|
(7)
-29%
|
(8)
-15%
|
(9)
-13%
|
(10)
-11%
|
(8)
+19%
|
(13)
-68%
|
(13)
-2%
|
(14)
-5%
|
(13)
+9%
|
(14)
-10%
|
(15)
-4%
|
(16)
-12%
|
(20)
-24%
|
(25)
-21%
|
(28)
-13%
|
(29)
-2%
|
(24)
+15%
|
(44)
-82%
|
(16)
+65%
|
(13)
+16%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
(3)
|
(3)
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
(0)
|
(2)
|
0
|
(2)
|
(2)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
4
|
4
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(25)
|
0
|
(25)
|
(25)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
|
| Pre-Tax Income |
(1)
N/A
|
(1)
+19%
|
(0)
+46%
|
(0)
+19%
|
(2)
-859%
|
(2)
+0%
|
(2)
+6%
|
(2)
-2%
|
(0)
+80%
|
(1)
-59%
|
(1)
-11%
|
(1)
+31%
|
(1)
-18%
|
(0)
+37%
|
(0)
-3%
|
(1)
-95%
|
(1)
-35%
|
(2)
-103%
|
(4)
-93%
|
(5)
-33%
|
(7)
-29%
|
(8)
-16%
|
(9)
-13%
|
(5)
+38%
|
(8)
-44%
|
(9)
-19%
|
(9)
-1%
|
(14)
-53%
|
(13)
+9%
|
(14)
-7%
|
(15)
-6%
|
(17)
-15%
|
(21)
-24%
|
(25)
-18%
|
(29)
-16%
|
(29)
-1%
|
(52)
-78%
|
(45)
+13%
|
(41)
+9%
|
(39)
+6%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(1)
|
(1)
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(4)
|
(5)
|
(7)
|
(8)
|
(9)
|
(5)
|
(8)
|
(9)
|
(9)
|
(14)
|
(13)
|
(14)
|
(15)
|
(17)
|
(21)
|
(25)
|
(29)
|
(29)
|
(52)
|
(45)
|
(41)
|
(39)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(1)
N/A
|
(1)
+9%
|
(0)
+46%
|
(0)
+19%
|
(2)
-859%
|
(2)
+0%
|
(2)
+6%
|
(2)
-2%
|
(0)
+80%
|
(1)
-59%
|
(1)
-11%
|
(1)
+31%
|
(1)
-18%
|
(0)
+37%
|
(0)
-3%
|
(1)
-92%
|
(1)
-29%
|
(2)
-104%
|
(4)
-83%
|
(5)
-33%
|
(6)
-33%
|
(7)
-14%
|
(8)
-17%
|
(5)
+38%
|
(8)
-47%
|
(9)
-22%
|
(10)
-3%
|
(15)
-59%
|
(15)
N/A
|
(15)
0%
|
(17)
-9%
|
(19)
-16%
|
(26)
-36%
|
(31)
-18%
|
(34)
-10%
|
(34)
+2%
|
(52)
-55%
|
(45)
+13%
|
(41)
+9%
|
(39)
+6%
|
|
| EPS (Diluted) |
-0.02
N/A
|
-0.02
N/A
|
-0.01
+50%
|
-0.01
N/A
|
-0.08
-700%
|
-0.08
N/A
|
-0.07
+12%
|
-0.07
N/A
|
-0.01
+86%
|
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.03
-50%
|
-0.04
-33%
|
-0.06
-50%
|
-0.05
+17%
|
-0.06
-20%
|
-0.03
+50%
|
-0.06
-100%
|
-0.04
+33%
|
-0.06
-50%
|
-0.08
-33%
|
-0.07
+12%
|
-0.07
N/A
|
-0.05
+29%
|
-0.07
-40%
|
-0.09
-29%
|
-0.11
-22%
|
-0.09
+18%
|
-0.08
+11%
|
-0.12
-50%
|
-0.11
+8%
|
-0.1
+9%
|
-0.09
+10%
|
|
Switch to:
Switch to:
See Also
Discover More
